Crinetics Pharmaceuticals, Inc. revenue for the last year amounted to 4.01 M USD, the most of which — 4.01 M USD — came from its highest performing source at the moment, Novel Therapeutics, the year earlier bringing 4.74 M USD. The greatest contribution to the revenue figure was made by United States and Australia — last year it brought Crinetics Pharmaceuticals, Inc. 4.01 M USD, and the year before that — 4.74 M USD.